Pharvaris N.V.
PHVS
$35.14
$1.103.23%
NASDAQ
| 06/30/2026 | 12/31/2025 | 09/30/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -5.81% | -46.84% | 5.32% | 5.32% | -61.30% |
| Total Depreciation and Amortization | 75.11% | 25.88% | 156.58% | 156.58% | 58.19% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -74.14% | 199.08% | -50.93% | -50.93% | 4,977.48% |
| Change in Net Operating Assets | 111.59% | 35.80% | 241.70% | 241.70% | 95.33% |
| Cash from Operations | -26.82% | -18.58% | 1.95% | 1.95% | -14.19% |
| Capital Expenditure | -262.43% | 98.95% | 93.50% | 93.50% | 143.75% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -262.43% | 98.95% | 93.50% | 93.50% | 143.75% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -166.09% | -149.25% | 3.49% | 3.49% | 56.45% |
| Issuance of Common Stock | 28,281,550.00% | -43.09% | 16,722.51% | 16,722.51% | -99.91% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -1,091,090.00% | -1,091,090.00% | -- |
| Cash from Financing | 464,949.23% | -47.64% | 17,099.96% | 17,099.96% | -107.47% |
| Foreign Exchange rate Adjustments | 147.53% | -99.18% | 99.40% | 99.40% | -377.93% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 294.29% | -67.87% | 459.40% | 459.40% | -57.20% |